According to a new report by Polaris Market Research, the global chemiluminescence immunoassay market was valued at USD 12.14 billion in 2024 and is projected to reach USD 18.97 billion by 2034, expanding at a CAGR of 4.6% from 2025 to 2034. Growth is underpinned by rising chronic and infectious disease burden, expanding demand for advanced diagnostic solutions, and accelerating...